KACHARIA DYES & CHEMICALS PVT. LTD.

PB Fintech Q1 Results: Net profit nearly doubles to ₹163 crore; revenue climbs 40%

PB Fintech reported a Q1FY27 net profit of ₹163 crore, a 92% increase from last year, with revenue rising 40% YoY to ₹1,888 crore. However,…

After FSSAI's Old Monk action, could Minty Jamun and Mango Chilli Vodka face scrutiny?

These niche vodkas are legally protected under a separate “Premix/Flavoured Vodka” category — when a brand produces a flavoured vodka, it is not attempting to…

CREDAI, NAREDCO hail RBI policy, stable home loan interest rate to help sustain housing demand

The real estate industry's leading organizations, CREDAI and NAREDCO, applaud the RBI's decision to maintain the current repo rate. This move stabilizes home loan rates,…

India bonds rally on 'dovish' RBI hold, lower oil prices

Indian government bonds surged on Wednesday, with yields falling below important levels. The Reserve Bank of India decided to keep the repo rate steady, in…

The next RBI policy: Likely more of the same

The RBI's decision to keep the repo rate unchanged and retain a neutral stance signals policy continuity over pre-emptive action. With inflation seen as temporary,…

Dow Jones| Nasdaq | US Stock Market Today | Live: S&P 500, Dow futures edge higher as Mideast hopes offset SpaceX, AMD drag

MV Electrosystems, Juniper Green Energy shares to list tomorrow. Here's what GMP signals ahead of debut

MV Electrosystems and Juniper Green Energy will debut on the exchanges on August 6 with contrasting listing expectations. MV Electrosystems commands a strong grey market…

Navin Fluorine Q1 Results: Net profit more than doubles to ₹243 crore as margins expand; revenue rises 44%

Navin Fluorine International reported a consolidated net profit of ₹243.31 crore for the June quarter, a 108% YoY increase. Revenue from operations rose to ₹1,045.08…

Natco challenges Novartis’s second patent for cancer drug ribociclib in Delhi High Court

Natco claims the new patent unlawfully extends Novartis’s market monopoly over the breast cancer medicine past 2027; Delhi High Court issues notices to all parties.

Quote of the day by Paul Tudor Jones: "Failure will give you a tattoo that will stay with you your whole life, and sometimes it’s a really good thing"

Paul Tudor Jones said failure leaves lasting lessons that strengthen judgment, resilience and decision-making. He urged investors and professionals to embrace setbacks as learning opportunities,…

Stock to buy after Q1 results 2026: Emkay sees over 32% upside in this healthcare stock

Emkay Global Financial Services maintains its 'Buy' rating on Park Medi World, raising the target price to ₹375 following strong June quarter results, with revenue…